Liquid Biopsies Flashcards

1
Q

Describe liquid biopsies

A

Liquid biopsies is one of the factors used for personalised medicine with its role primarily acting as a biomarkers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a liquid biopsie?

A
  • Sampling and analysis of non-solid biological tissue, primarily blood.
  • Blood is used as it recieves inputs from all organs of the body including any tumours
  • Other examples include saliva, pleural liquid, urine, CSF liquid
  • It is a minimally invasive technology for detection of molecular biomarkers
  • Solid biopsie is a very invasive technique
  • Representative of the tissues from which it has spread.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

State an example of an established liquid biopsie?

A
  • Amniotic fluid analysis
  • Invasive
  • Non invasive, pre natal tests are being used (circulating free DNA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are CTCs and what is their biomarker role for in liquid biopsies?

A
  • CTC = Circulating tumour cells
  • Rare Cells that have detached from a tumour and travel through the bloodstream to other parts of the body- single cells or clusters.
  • Marker for tumour growth and negative cancer prognosis and treatment response.
  • Found in a high background of normal cells! - sensitive and specific methods are needed to study them
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the isolation, characterisation and analysis of CTs based on?

A
  • Isolation and charaterisation: Biological and/or physical properties, Transcripts via PCR performed on total RNA from cells
  • Downstream analysis: Techniques like NGS, flow cytometry, FISH etc. , Used to study genomics, phenotype, protemics etc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the sources of ctDNA and featurs about it (3)?

A
  • ctDNA = Circulating tumour DNA - cancer > ^ ctDNA
  • Present in different fluids: plasma, serum, urine and others: Low concentration (1-50ng DNA/mL plasma).
  • Amount highly variable for person to person and depending on health status in the same person (increase in cancer, trauma, etc.).
  • Presence of permanent genomic DNA background in plasma (from cell turnover)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the physical features of cDNA

A

Highly fragmented (many pieces with different sizes) but with specific size range (<500bp)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ctDNA, What technique can be used to analyse and where is it found in centrifugation of liquid biopsie?

A
  • NGS used primarily
  • Provides information of current genetic make-up (including irregularities/mutations) with 80-95% specificity and 60-85% sensitivity.
  • Found in plasma in cDNA (circulating free DNA)
  • Extract ctDNA and isolate tDNA from there
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is ctDNA isolated after the centrifugation of liquid biopsie?

A
  1. After centrifugation, transfer supernatant to a clean polypropylene tube and freeze it if needed
  2. Isolation of cDNA using magnetic bead, cellulose-based or silica-based systems.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What techniques are used for the analysis of ctDNA and state what they can detect?

A
  • Next Generation Sequencing (NGS), Digital Droplet PC (ddPCR), array CGH:
  • Amplifications and deletions
  • Translocations
  • Point mutations
  • Chromosomes abnormalities
  • Epigenetic status (methylation)
  • Real Time Quantitative Polymerase Chain reaction (qPCR):
  • cDNA presence quantification
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

State the advantages (5) of using liquid biopsies over solid biopsies?

A
  • Advantages:
  • Lower invasiveness
  • Higher patient compliance
  • Higher cost effectiveness
  • Allow repeated access and multiple sampling
  • No special training required for extraction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

State the disadvantages (3) of using liquid biopsies over solid biopsies?

A
  • Disadvantages:
  • Low amount of material
  • Early diagnosis is difficult
  • Data interpretation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe features of cancer as reasons as to why liquid bipsoies are a good method for cancer biomarkers?

A

Key features of cancer:

  1. Cancer is a heterogeneous disease, therefore..
    a. Heteogenous = condition with several root causes
  2. Molecular properties within a tumour differ arise and also between metastatic sites. Therefore..
    a. Metastatic sites = secondary malignant growths
  3. Primary tumour information may not reflect the current disease condition.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe features of cancer as reasons as to why liquid biopsies are a good method for cancer biomarkers?

A
  • Why liquid biopsies are used:
  • No need to identify the tumour site before taking a biopsy and allow repeating sampling.
  • Allows for identification of tissue specific markers and the different tumour sites
  • Allow analysis of tissues difficult to access.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What can the cancer biomarkers of liquid biopsies be used for?

A
  • Early detection, screening and testing
  • Individual genetic makeup
  • Identification of resistance mechanisms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What type of cancer can liquid biopsies detect for?

A
  • Breast cancer (main once)
  • Colorectal
  • Lung
  • Prostate
17
Q

State the reasoning of the usage of cancer biomarkers from liquid biopsies in modern times

A
  • Promising biomarkers that need to be clinically validated
  • Not implemented as diagnosis tool yet
  • But that provides highly specific and complementary information
18
Q

State 2 examples of FDA-approved diagnostic tests?

A
    1. Detection of EGFR mutations in lung cancer
      a. EGFR = epidermal growth factor receptor
    1. Pan-tumour liquid biopsy test for patients with advanced solid cancer
19
Q

How can biomarkers be validated for diagnostic usage?

A

Standardization of techniques along with multicentre studies involving large cohorts of patients and controls are required to validate CTs and tDNA as clinical biomarkers.